openPR Logo
Press release

Antacids Sector Dynamics: Factors Driving the US$ 22 Billion Market by 2033

03-19-2024 10:13 PM CET | Chemicals & Materials

Press release from: Fact.MR

Antacids Market

Antacids Market

According to a report from Fact.MR, the global antacids market was worth US$ 14 billion in 2023. The market is expected to grow and reach a size of US$ 22 billion by 2033. This means the market is projected to increase at a rate of 4.6% annually from 2023 to 2033.

๐—š๐—ฒ๐˜ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐—ฝ๐˜†:

https://www.factmr.com/connectus/sample?flag=S&rep_id=4328

Antacids, the go-to remedy for heartburn and indigestion, have long been a staple in households worldwide. From chalky tablets to fruity-flavored liquids, these over-the-counter medications provide quick relief for those uncomfortable moments after a heavy meal or a spicy dish. But what drives the growth of this industry, and what does the future hold for antacids?

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐˜€:

Changing Lifestyles:

In today's fast-paced world, people often resort to fast food and irregular eating habits. These lifestyle changes contribute to an increase in digestive issues like acid reflux and heartburn, leading to a higher demand for antacids.

Aging Population:

With the global population aging, the prevalence of gastrointestinal problems also rises. Older adults are more prone to conditions like gastroesophageal reflux disease (GERD), prompting them to rely on antacids for relief.

Increased Awareness:

As information becomes more accessible, people are becoming increasingly aware of the symptoms and treatment options for digestive disorders. This heightened awareness drives individuals to seek relief from over-the-counter antacids.

Innovation and Product Development:

The antacid industry continuously innovates to cater to evolving consumer preferences. From chewable tablets to liquid gels, manufacturers strive to offer convenient and effective solutions for acid-related discomfort.

Globalization:

Antacids are not confined to specific regions but have a global market. As urbanization spreads and access to healthcare improves in developing countries, the demand for antacids is expected to rise.

๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—ข๐˜‚๐˜๐—น๐—ผ๐—ผ๐—ธ:

Technological Advancements:

The future of antacids may see advancements in formulation techniques and delivery methods. Innovations such as nanoencapsulation could enhance the efficacy and duration of antacid effects.

Personalized Medicine:

With the advent of personalized medicine, antacids tailored to individual needs could become a reality. Genetic testing and biomarker analysis may enable healthcare providers to prescribe specific antacid formulations optimized for each patient.

Natural Remedies:

The shift towards natural and herbal remedies may influence the antacid market. Manufacturers may explore plant-based ingredients and traditional remedies with proven efficacy in soothing digestive discomfort.

Digital Health Solutions:

Technology-driven solutions like mobile applications and wearable devices could revolutionize how individuals manage digestive health. These platforms may provide personalized dietary recommendations and track symptoms, complementing the use of antacids.

Environmental Sustainability:

Concerns about environmental sustainability are prompting manufacturers to develop eco-friendly packaging and production processes. Biodegradable materials and energy-efficient manufacturing practices may shape the future of the antacid industry.

๐—ฅ๐—ฒ๐—พ๐˜‚๐—ฒ๐˜€๐˜ ๐—™๐—ผ๐—ฟ ๐—™๐—ฅ๐—˜๐—˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4328

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐—ฃ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€:

Bayer AG
GlaxoSmithKline plc
Mylan N.V.
Novartis AG
Sanofi
Procter & Gamble
Reddy's Laboratories Ltd.
Reckitt Benckiser Group plc
Sun Pharmaceuticals Ltd.
Takeda Pharmaceutical Company Limited
Pfizer Inc.

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ:

Top companies are using various strategies like forming partnerships, ensuring quality, buying other companies, setting product standards, managing how products get to customers, and working together with others. They're doing this to sell more in different places and be better than their rivals. Big antacid makers are busy making new things and bringing them out while being careful to follow the rules about safety to keep customers happy.

For example,

In 2020, Lupin started selling Horizon Therapeutics PLC's Vimovo delayed-release tablets. These tablets help lessen the chance of getting stomach ulcers from taking naproxen.

๐—•๐—ฟ๐—ผ๐˜„๐˜€๐—ฒ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ @ https://www.factmr.com/report/4328/antacids-market

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

By Drug Class :
Proton Pump Inhibitors
H2 Antagonists
Acid Neutralizers

By Formulation :
Tablets
Liquid
Powder
Others

By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region :
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

๐—˜๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ฒ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—ฅ๐—ฒ๐—น๐—ฎ๐˜๐—ฒ๐—ฑ ๐—ฆ๐˜๐˜‚๐—ฑ๐—ถ๐—ฒ๐˜€ ๐—ฃ๐˜‚๐—ฏ๐—น๐—ถ๐˜€๐—ต๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—™๐—ฎ๐—ฐ๐˜.๐— ๐—ฅ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต:

Glycobiology Market:

https://www.factmr.com/report/glycobiology-market

Endodontic Reparative Cement Market:

https://www.factmr.com/report/endodontic-reparative-cement-market

IV Infusion Pump Accessories Market:

https://www.factmr.com/report/iv-infusion-pump-accessories-market

Canine Stem Cell Therapy Market:

https://www.factmr.com/report/canine-stem-cell-therapy-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

๐€๐›๐จ๐ฎ๐ญ ๐…๐š๐œ๐ญ.๐Œ๐‘
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antacids Sector Dynamics: Factors Driving the US$ 22 Billion Market by 2033 here

News-ID: 3436908 • Views: โ€ฆ

More Releases from Fact.MR

Craft Spirit Market Anticipates $ 59.47 Billion Valuation by 2034, Driven by 29% CAGR
05-21-2024 | Food & Beverage
Fact.MR
Craft Spirit Market Anticipates $ 59.47 Billion Valuation by 2034, Driven by 29% โ€ฆ
According to the most recent market analysis conducted by knowledgeable analysts at Fact.MR, the size of the worldwide craft spirit market is estimated to be worth US$ 20.5 billion in 2023 and is expected to grow at a CAGR of 29% to reach a valuation of US$ 230 billion by the end of 2033. Craft spirits are growing in popularity because of their exceptional flavor, quality, and distinctiveness. The craft spiritsโ€ฆ
Bank Kiosk Market Forecasted to Expand Rapidly, Projecting US$ 80 Billion Value by 2033, with 15% CAGR
Bank Kiosk Market Forecasted to Expand Rapidly, Projecting US$ 80 Billion Value โ€ฆ
A recent analysis by knowledgeable experts at Fact.MR values the worldwide bank kiosk market at US$ 18.5 billion in 2023 and projects it will grow at a CAGR of 15% to reach US$ 80 billion by the end of 2033. An automated self-service device called a bank kiosk offers customers a range of banking services without the need for human support. A vital component of the contemporary banking infrastructure, bank kiosksโ€ฆ
Smart Badges Market To Witness Exponential Growth, Expected to Hit US$ 50 Billion by 2033 at 9% CAGR
Smart Badges Market To Witness Exponential Growth, Expected to Hit US$ 50 Billio โ€ฆ
The smart badge market is expected to grow at a remarkable compound annual growth rate (CAGR) of 9% from 2023 to 2033, from its estimated valuation of US$ 21 billion in 2023 to US$ 50 billion by 2033. An electrical gadget with an embedded memory or microcontroller in the shape of a touch pad is called a smart badge. It establishes a connection with a reader by short-range wireless connectivity orโ€ฆ
Pod Vapes Market Is Forecasted To Increase At A CAGR Of 12.5% By 2033: Fact.MR Report
Pod Vapes Market Is Forecasted To Increase At A CAGR Of 12.5% By 2033: Fact.MR R โ€ฆ
The global pod vape market, valued at USD 2.52 billion in 2023, is projected to grow significantly, reaching USD 8.18 billion by 2033. This expansion represents a compound annual growth rate (CAGR) of 12.5% over the decade. The Pod Vape Industry sales study offers a comprehensive analysis on diverse features including production capacities, Pod Vape demand, product developments, sales revenue generation and Pod Vape market outlook across the globe. market research reportโ€ฆ

All 5 Releases


More Releases for Antacids

Antacids Market Analysis by Key Players & Industry Size 2027
Allied Market Research published a report, titled, โ€œAntacids Market: Global Opportunity Analysis and Industry Forecast 2019โ€“2027". According to the report, the Global Antacids industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10646 Major players analyzed include GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC, Boehringerโ€ฆ
03-15-2021 | Health & Medicine
Fact.MR
Antacids Market to soar with CAGR of ~4% by 2025
Online pharmacies will grow as a prominent sales channel in the antacids market. A marked rise in the popularity of this channel is attributable to consumer-centric deals, such as attractive discounts and home delivery services. There is no permanent panacea for acid reflux and heartburn, which inadvertently is expected to retain consumersโ€™ reliance on antacids. This Press Release will help you to understand the market Statistics of European Region. Click HERE Toโ€ฆ
Antacids Market Companies Overview 2017 - 2025
The global antacids market features a large number of companies, both international as well as regional, which serve the global market through a large number of products varieties and brands. The level of competition is thus intense and the high focus of companies on new markets and growth opportunities is evident through the several strategic collaborations to have taken place in the market in the past years, observes Transparency Marketโ€ฆ
Antacids Market Overview and Industry Outlook 2020
Global Antacids Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Antacids Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projectedโ€ฆ
Antacids Market will Clock a 3.7% CAGR Between 2017 and 2025
The worldwide antacids market is a choc-o-bloc with large companies that hold prominence due to their product offerings and presence across geographies, observes Transparency Market Research (TMR). R&D initiatives for the introduction of novel therapies, improving efficacy of existing drugs are the focus of key players in this market to gain competitive advantage. These players are also seeking strategic partnerships and business alliances to strengthen their research expertise as wellโ€ฆ
Global Antacids Market to Surpass US$18.7 bn by 2025
With a large pool of established players such as AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Dr. Reddyโ€™s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble, Reckitt Benckiser Group plc, Sanofi, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Ltd., and Valeant Pharmaceuticals International Inc., the worldwide antacids market features a competitive and a fragmented vendor landscape, notes a research report by Transparency Market Research (TMR). Development of novel therapiesโ€ฆ